NO20021859D0 - New digosaccharides, their preparation as well as pharmaceutical preparations - Google Patents

New digosaccharides, their preparation as well as pharmaceutical preparations

Info

Publication number
NO20021859D0
NO20021859D0 NO20021859A NO20021859A NO20021859D0 NO 20021859 D0 NO20021859 D0 NO 20021859D0 NO 20021859 A NO20021859 A NO 20021859A NO 20021859 A NO20021859 A NO 20021859A NO 20021859 D0 NO20021859 D0 NO 20021859D0
Authority
NO
Norway
Prior art keywords
digosaccharides
preparation
new
well
pharmaceutical preparations
Prior art date
Application number
NO20021859A
Other languages
Norwegian (no)
Other versions
NO20021859L (en
NO323409B1 (en
Inventor
Pierre Mourier
Elisabeth Perrin
Christian Viskov
Jean-Marie Stutzmann
Florence Wahl
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20021859D0 publication Critical patent/NO20021859D0/en
Publication of NO20021859L publication Critical patent/NO20021859L/en
Publication of NO323409B1 publication Critical patent/NO323409B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Abstract

The invention concerns oligosaccharides of formula (I), their mixtures, their diastereomers, methods for preparing them and pharmaceutical compositions containing them.
NO20021859A 1999-10-22 2002-04-19 New oligosaccharides, their preparation, pharmaceutical preparations containing the oligosaccharides and their use. NO323409B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9913182A FR2800074B1 (en) 1999-10-22 1999-10-22 NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR2000/002897 WO2001029055A2 (en) 1999-10-22 2000-10-18 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same

Publications (3)

Publication Number Publication Date
NO20021859D0 true NO20021859D0 (en) 2002-04-19
NO20021859L NO20021859L (en) 2002-06-13
NO323409B1 NO323409B1 (en) 2007-04-30

Family

ID=9551218

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021859A NO323409B1 (en) 1999-10-22 2002-04-19 New oligosaccharides, their preparation, pharmaceutical preparations containing the oligosaccharides and their use.

Country Status (31)

Country Link
EP (1) EP1226148B1 (en)
JP (1) JP4733329B2 (en)
KR (2) KR100778166B1 (en)
CN (1) CN1241932C (en)
AT (1) ATE534656T1 (en)
AU (1) AU781414B2 (en)
BR (1) BR0014939A (en)
CA (1) CA2388369C (en)
CY (1) CY1112274T1 (en)
CZ (1) CZ303255B6 (en)
DK (1) DK1226148T3 (en)
EA (1) EA004046B1 (en)
EE (1) EE05091B1 (en)
ES (1) ES2376409T3 (en)
FR (1) FR2800074B1 (en)
HK (1) HK1050535A1 (en)
HR (1) HRP20020330A2 (en)
HU (1) HU229385B1 (en)
IL (2) IL149154A0 (en)
ME (1) MEP9309A (en)
MX (1) MXPA02003945A (en)
NO (1) NO323409B1 (en)
NZ (1) NZ518539A (en)
PL (1) PL204623B1 (en)
PT (1) PT1226148E (en)
RS (1) RS50829B (en)
SK (1) SK287459B6 (en)
TR (1) TR200201102T2 (en)
UA (1) UA72545C2 (en)
WO (1) WO2001029055A2 (en)
ZA (1) ZA200203102B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4676048B2 (en) * 2000-07-10 2011-04-27 生化学工業株式会社 Demyelinating disease treatment
DE50105650D1 (en) * 2000-12-16 2005-04-21 Aventis Pharma Gmbh USE OF LOW-MOLECULAR HEPARIN FOR THE TREATMENT OF OSTEOARTHROSIS
DE10121003A1 (en) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
EP2402753A1 (en) 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
FR2844808B1 (en) * 2002-09-23 2005-02-25 Aventis Pharma Sa METHOD OF DETERMINING SPECIFIC GROUPS CONSISTING OF HEPARINS OR HEPARINS OF LOW MOLECULAR WEIGHT
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
FR2857971B1 (en) * 2003-07-24 2005-08-26 Aventis Pharma Sa MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
EP1580197A1 (en) * 2004-03-24 2005-09-28 Aventis Pharma S.A. Method for quantitatively determining specific groups constituting heparins or low molecular wieght heparins using HPLC
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
DE102005017799A1 (en) * 2005-04-18 2006-10-19 Abbott Gmbh & Co. Kg Use of heparin- or heparin derivative to treat illness associated with neurite plasticity or -growth defects, modulates interaction between Nogo receptor and ligands
US8101733B1 (en) 2006-06-27 2012-01-24 Momenta Pharmaceuticals, Inc. Methods of evaluating mixtures of polysaccharides
US7790466B1 (en) 2007-01-26 2010-09-07 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
US7968082B1 (en) 2007-01-26 2011-06-28 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by NMR
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2256138A1 (en) 2009-05-05 2010-12-01 Sanofi-Aventis Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent
FR2949114B1 (en) * 2009-08-14 2011-08-26 Sanofi Aventis FGF RECEPTOR ACTIVATORY N-ACYLATED OCTASACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2949115B1 (en) * 2009-08-14 2012-11-02 Sanofi Aventis FGF RECEPTOR ACTIVATOR N-SULFATE OLIGOSACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ES2817779T3 (en) 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluation of heparin preparations
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102864191A (en) * 2011-12-16 2013-01-09 深圳市海普瑞药业股份有限公司 Heparin disaccharide mixture and preparation method and application thereof
CN104910217B (en) * 2015-06-19 2018-04-17 天津红日药业股份有限公司 Reference compound for Fondaparinux sodium quality control
CZ308106B6 (en) * 2016-06-27 2020-01-08 Contipro A.S. Unsaturated derivatives of polysaccharides, preparing and using them
CN110092848A (en) * 2019-05-14 2019-08-06 山东辰龙药业有限公司 A kind of preparation method of Bemiparin sodium

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519987A1 (en) * 1982-01-15 1983-07-22 Choay Sa Uronic acid derivs. - useful as glycoside intermediates or hapten(s)
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
FR2764511B1 (en) * 1997-06-13 2000-09-08 Sanofi Sa COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF ARTERIAL THROMBOSIS AND USE OF A FACTOR XA INHIBITOR ALONE AND / OR IN COMBINATION WITH A PLAQUET ANTIAGGREGANT
JP4166851B2 (en) * 1997-09-29 2008-10-15 生化学工業株式会社 Novel inhibitor of ischemia / reperfusion injury

Also Published As

Publication number Publication date
PT1226148E (en) 2012-01-24
EE05091B1 (en) 2008-10-15
AU7930200A (en) 2001-04-30
PL363052A1 (en) 2004-11-15
CN1379781A (en) 2002-11-13
HRP20020330A2 (en) 2004-04-30
JP4733329B2 (en) 2011-07-27
CA2388369A1 (en) 2001-04-26
DK1226148T3 (en) 2012-03-19
ATE534656T1 (en) 2011-12-15
IL149154A (en) 2008-04-13
HUP0203821A2 (en) 2003-04-28
WO2001029055A2 (en) 2001-04-26
KR20020063881A (en) 2002-08-05
MXPA02003945A (en) 2002-10-23
ES2376409T3 (en) 2012-03-13
CN1241932C (en) 2006-02-15
PL204623B1 (en) 2010-01-29
KR100778166B1 (en) 2007-11-27
SK287459B6 (en) 2010-10-07
JP2003512385A (en) 2003-04-02
SK5272002A3 (en) 2002-08-06
TR200201102T2 (en) 2002-12-23
KR100872215B1 (en) 2008-12-05
EA004046B1 (en) 2003-12-25
BR0014939A (en) 2002-06-18
EP1226148B1 (en) 2011-11-23
MEP9309A (en) 2011-12-20
HUP0203821A3 (en) 2003-10-28
HRP20020330B1 (en) 2013-01-31
WO2001029055A3 (en) 2002-02-14
FR2800074B1 (en) 2001-12-21
ZA200203102B (en) 2003-09-23
CZ303255B6 (en) 2012-06-27
EP1226148A2 (en) 2002-07-31
AU781414B2 (en) 2005-05-19
EE200200208A (en) 2003-06-16
NZ518539A (en) 2004-10-29
RS50829B (en) 2010-08-31
IL149154A0 (en) 2002-11-10
UA72545C2 (en) 2005-03-15
HU229385B1 (en) 2013-11-28
FR2800074A1 (en) 2001-04-27
KR20070087263A (en) 2007-08-27
NO20021859L (en) 2002-06-13
YU29802A (en) 2006-01-16
CY1112274T1 (en) 2015-12-09
EA200200479A1 (en) 2002-10-31
HK1050535A1 (en) 2003-06-27
CZ20021385A3 (en) 2002-07-17
CA2388369C (en) 2011-02-01
NO323409B1 (en) 2007-04-30

Similar Documents

Publication Publication Date Title
NO20021859D0 (en) New digosaccharides, their preparation as well as pharmaceutical preparations
NO20024177L (en) Pharmaceutical preparations containing azetidine derivatives, the new azetidine derivatives and their preparation
NO20026064D0 (en) New connections
DE60112609D1 (en) Pyrazolopyridine
DE60204452D1 (en) [1,5] pyridine derivatives
DK1140993T3 (en) Glycopeptide derivatives and pharmaceutical preparations containing them
SE9904505D0 (en) Novel compounds
SE9901875D0 (en) Novel compounds
BR0208741A (en) Piperidine Derivatives
PA8495101A1 (en) DERIVATIVES OF 13-METHYLERITROMYCIN
AU2002239348A1 (en) Pyrazolopyridine derivatives
NO971625L (en) Novel peptides with immunomodulatory effects
DK1194415T3 (en) New piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing them and a process for their preparation
YU72802A (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof
ATE274515T1 (en) PYRAZOLOPYRIDINE DERIVATIVES
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
SE9904128D0 (en) Novel compounds
NO991589L (en) Novel 3-, 5- and / or 6-substituted analogues of swainsonine, methods for their preparation and their use as therapeutic agents
DK0989994T3 (en) Streptogramin derivatives, their preparation and preparations containing them
SE9803107D0 (en) Novel Compunds
NO20020914L (en) Alkoxy-substituted benzimidazole compounds, preparations containing them and their applications
SE9803277D0 (en) Novel compounds
NO20022712L (en) Unsaturated 14,15-cyclopropanandrostanes, processes for their preparation, and pharmaceutical preparations containing these compounds
DK1157028T3 (en) New 11.beta-substituted steroid derivatives, processes for their preparation and intermediates thereof, their use as pharmaceuticals and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees